ORAL CYCLOSPORINE FOR SEVERE CHRONIC IDIOPATHIC URTICARIA AND ANGIOEDEMA

被引:73
作者
FRADIN, MS
ELLIS, CN
GOLDFARB, MT
VOORHEES, JJ
机构
[1] Dermatopharmacology Unit, The Department of Dermatology, University of Michigan Medical Center, Ann Arbor, Michigan
关键词
D O I
10.1016/0190-9622(91)70308-O
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Three patients with chronic urticaria, two of whom also had angioedema, were treated with oral cyclosporine, 6 mg/kg per day. In each patient, complete resolution of symptoms occurred within the first week of therapy; however, all patients eventually had to stop therapy as a result of side effects. On stopping therapy, all side effects resolved and the urticaria and angioedema recurred. Although cyclosporine therapy is not an appropriate treatment of urticaria, the results of this preliminary study suggest that cyclosporine and related drugs should be investigated in the treatment of mast cell-mediated diseases.
引用
收藏
页码:1065 / 1067
页数:3
相关论文
共 22 条
[1]  
CIRILLO R, 1990, J IMMUNOL, V144, P3891
[2]   EFFECT OF DIVALENT-CATIONS AND METABOLIC ENERGY ON ANAPHYLACTIC HISTAMINE-RELEASE FROM RAT PERITONEAL MAST-CELLS [J].
DIAMANT, B ;
GROSMAN, N ;
SKOV, PS ;
THOMLE, S .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1974, 47 (03) :412-424
[3]   CYCLOSPORINE-A INHIBITS RAT MAST-CELL ACTIVATION [J].
DRABEROVA, L .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (07) :1469-1473
[4]   STUDIES OF THE CELLULAR INFILTRATE OF CHRONIC IDIOPATHIC URTICARIA - PROMINENCE OF LYMPHOCYTES-T, MONOCYTES, AND MAST-CELLS [J].
ELIAS, J ;
BOSS, E ;
KAPLAN, AP .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1986, 78 (05) :914-918
[5]   ANTIALLERGIC PROPERTIES OF CYCLOSPORINE-A - INHIBITION OF MEDIATOR RELEASE FROM HUMAN BASOPHILS AND RAT BASOPHILIC LEUKEMIA-CELLS (RBL-2H3) [J].
EZEAMUZIE, CI ;
ASSEM, ESK .
IMMUNOPHARMACOLOGY, 1990, 20 (01) :31-43
[6]   INHIBITION OF HISTAMINE-RELEASE FROM HUMAN LUNG AND RAT PERITONEAL MAST-CELLS BY CYCLOSPORINE-A [J].
EZEAMUZIE, IC ;
ASSEM, ESK .
AGENTS AND ACTIONS, 1990, 30 (1-2) :110-113
[7]   MANAGEMENT OF PATIENTS AND SIDE-EFFECTS DURING CYCLOSPORINE THERAPY FOR CUTANEOUS DISORDERS [J].
FRADIN, MS ;
ELLIS, CN ;
VOORHEES, JJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 23 (06) :1265-1275
[8]  
GREEN GR, 1965, ANN ALLERGY, V23, P30
[9]   ORAL CYCLOSPORINE IN THE TREATMENT OF INFLAMMATORY AND NONINFLAMMATORY DERMATOSES - A CLINICAL AND IMMUNOPATHOLOGIC ANALYSIS [J].
GUPTA, AK ;
ELLIS, CN ;
NICKOLOFF, BJ ;
GOLDFARB, MT ;
HO, VC ;
ROCHER, LL ;
GRIFFITHS, CEM ;
COOPER, KD ;
VOORHEES, JJ .
ARCHIVES OF DERMATOLOGY, 1990, 126 (03) :339-350
[10]  
HULTSCH T, 1990, J IMMUNOL, V144, P2659